TCF4 and glioblastoma: Despite the data obtained within this study demonstrating that HDI, not only affect TCF4 levels, but also suppress Wnt signaling activation; thus, making them not suitable for achieving a specific TCF4 inhibition, their promising effects displayed during GBM cell treatment encouraged us to better understand the mechanisms by which TSA and SAHA exert their anti-cancer action in GBM.